-
221
Small molecule inhibitors of the Dishevelled‐CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy
Published 2016-03-01“…EMBO Molecular Medicine…”
Get full text
Article -
222
SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1
Published 2018-01-01“…EMBO Molecular Medicine…”
Get full text
Article -
223
Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma
Published 2017-09-01“…EMBO Molecular Medicine…”
Get full text
Article -
224
CCR2+ monocytes infiltrate atrophic lesions in age‐related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice
Published 2013-10-01“…EMBO Molecular Medicine…”
Get full text
Article -
225
Oxidized LDL‐dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy
Published 2021-08-01“…EMBO Molecular Medicine…”
Get full text
Article -
226
Interferon‐beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization
Published 2016-05-01“…EMBO Molecular Medicine…”
Get full text
Article -
227
MED13‐dependent signaling from the heart confers leanness by enhancing metabolism in adipose tissue and liver
Published 2014-11-01“…EMBO Molecular Medicine…”
Get full text
Article -
228
COVID‐19 vaccination, time for a second breath?
Published 2022-02-01“…EMBO Molecular Medicine…”
Get full text
Article -
229
A DNA/HDAC dual‐targeting drug CY190602 with significantly enhanced anticancer potency
Published 2015-03-01“…EMBO Molecular Medicine…”
Get full text
Article -
230
IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells
Published 2023-10-01“…EMBO Molecular Medicine…”
Get full text
Article -
231
Getting to the heart of cardiovascular complications associated with inflammatory arthritis
Published 2025-04-01“…EMBO Molecular Medicine…”
Get full text
Article -
232
Interplay between fungal infections and autoimmunity: mechanisms and therapeutic perspectives
Published 2025-06-01“…EMBO Molecular Medicine…”
Get full text
Article -
233
Household triclosan and triclocarban effects on the infant and maternal microbiome
Published 2017-10-01“…EMBO Molecular Medicine…”
Get full text
Article -
234
HIF factors cooperate with PML‐RARα to promote acute promyelocytic leukemia progression and relapse
Published 2014-04-01“…EMBO Molecular Medicine…”
Get full text
Article -
235
Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
Published 2015-06-01“…EMBO Molecular Medicine…”
Get full text
Article -
236
Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?
Published 2015-07-01“…EMBO Molecular Medicine…”
Get full text
Article -
237
New CSF biomarkers on the block
Published 2016-09-01“…EMBO Molecular Medicine…”
Get full text
Article -
238
IL‐10 producing type 2 innate lymphoid cells prolong islet allograft survival
Published 2020-10-01“…EMBO Molecular Medicine…”
Get full text
Article -
239
Sarcoma treatment in the era of molecular medicine
Published 2020-10-01“…EMBO Molecular Medicine…”
Get full text
Article -
240
MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer
Published 2022-11-01“…EMBO Molecular Medicine…”
Get full text
Article